article · European Journal of Medicinal Chemistry

Single versus dual EGFR/PARP inhibition: Mechanistic rationale, synthetic approaches, pharmacophoric features, structure–activity relationships, and therapeutic perspectives

2026Tanta University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

PARP inhibition in cancer therapy
HER2/EGFR in Cancer Research
Computational Drug Discovery Methods

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ejmech.2026.119047

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.